enfaseexperimental t3 e17. leucemia mieloide crónica o “cml”
Published 5 years ago • 83 plays • Length 33:08Download video MP4
Download video MP3
Similar videos
-
1:18
unravelling the complex role of nlrp3 inflammasomes in cancer
-
2:21
novel insights from the randomized, phase 3 cll14 trial
-
1:37
u2' regimen with checkpoint inhibition in r/r cll and richter's transformation
-
4:37
metabolic adaptations to targeted therapy in flt3 mutated acute myeloid leukaemia
-
0:27
simulations of thrombotic adhesion to arteriosclerotic lesions
-
6:35
raffaele califano, esmo 2018 – mechanisms of resistance in non-small cell lung cancer
-
2:13
oncoalert cancer discovery academic recap with dr. stephen liu
-
1:50
slcvl raez #3 treating stage iii unresectable nsclc
-
4:43
first in-human trials of rovalpituzumab for sclc
-
2:39
leucemia mieloide aguda
-
1:58
entospletinib in combination with obinutuzumab in r/r cll
-
3:45
experimental oral therapy for high-risk cll shows promise
-
2:15
accurately diagnosing unresectable stage 3 nsclc
-
1:15
promises and challenges in up-and-coming cll therapies
-
3:31
resisitance mechanisms to venetoclax in patients with progressive cll
-
2:44
tcl: rationale and overview of the phase 3 alcanza trial
-
52:51
trevor moser, emsl, cryo-em tutorial at emsl integration 2020: visualizing the proteome - day 1
-
5:11
nsclc highlights from esmo 2017 | floriana morgillo